• Background: Urinalysis (UA) is considered the most important laboratory test in evaluating patients with kidney disease. Anecdotally, we have observed differences between results of UA performed by nephrologists compared with those performed by certified medical technologists or clinical laboratory scientists that could affect a clinician's diagnosis. Whether there are differences between UA performed by the clinical laboratory and that performed by a nephrologist was determined, and accuracy of diagnosis based on interpretation of the UA was compared. Methods: Urine samples were obtained from 26 patients with acute renal failure (ARF). An aliquot of urine was sent to the clinical laboratory for UA. Nephrologist A, blinded to the patient's clinical information, performed a UA on the other aliquot of urine, generated a report, and assigned the most likely diagnosis for ARF based on UA findings. Nephrologist B, also blinded to the clinical information, reviewed nephrologist A's UA reports and assigned a diagnosis for ARF to each report. Nephrologists A and B both assigned a diagnosis (or diagnoses) for the ARF based on laboratory UA results. These 4 sets of diagnoses were compared with those assigned by the consult nephrologists. 
U
RINALYSIS (UA) is the first and most important laboratory test in evaluating a patient with suspected kidney disease. [1] [2] [3] [4] [5] [6] [7] In the past, both clinicians and laboratory technologists have performed macroscopic (direct observation of physical characteristics and chemical dipstick testing) and microscopic examination of urine. Recently, there has been much greater reliance on the clinical laboratory and medical technologists for performance of UA, in part because of implementation of Clinical Laboratory Improvement Amendments (CLIA) of 1988. 8 Because CLIA mandates that most laboratory tests be performed by CLIA-certified personnel, who are usually technologists, UA performance is becoming a dying art among clinicians, 9 and many physicians have not been adequately trained to perform urine microscopy. 10 In our medical center, nephrologists and nephrologists in training perform the UA when a consultation for renal disease is requested. However, non-nephrologists frequently rely on the clinical laboratory to perform the UA. Anecdotally, we have observed major differences between the nephrologist and clinical laboratory evaluations of urinary sediment of a given patient that could affect the clinical diagnosis. The purpose of this study is to test the hypothesis that such differences exist and determine which UA evaluation and subsequent interpretation leads to the most accurate clinical diagnosis.
METHODS
Twenty-six patients admitted to the University of California Davis Medical Center (Sacramento, CA) between Sep-tember 2001 and March 2002 were enrolled after each patient's primary service requested nephrology consultation for evaluation of acute renal failure (ARF), defined as a daily increase in serum creatinine level greater than 0.5 to 1.0 mg/dL (Ͼ44 to 88 mol/L). Patients with urine output less than 40 mL/d or on dialysis therapy were excluded. Forty milliliters of urine were obtained from each patient within 24 hours after the consultation request and divided equally into 2 aliquots. One aliquot was used by nephrologist A to perform a UA, and the other was sent to the CLIA-certified clinical laboratory at the University of California Davis Medical Center for a clinical medical scientist (medical technologist) to perform a UA. The source of urine was documented as either clean catch or catheterized specimen.
Technical Performance of UA
Nephrologist A used a urinary dipstick to test for the presence of albumin and blood. Urine then was centrifuged at 2,500 rpm for 3 minutes. After decanting the supernatant, the pellet was resuspended in a minimal volume of urine by gently agitating the bottom of the centrifugation tube. A single drop of the resuspended pellet was transferred to a glass slide and placed under a glass cover slip for bright-field microscopic examination under low-power (original magnification ϫ100) and high-power (original magnification ϫ400) fields. Nephrologist A performed a microscopic examination of urine sediment and recorded his findings using the laboratory's standard report form. Elements of urine sediment listed in the standard laboratory form include the presence and quantification of white blood cells (WBCs), red blood cells (RBCs), renal tubular epithelial (RTE) cells, squamous epithelial cells, transitional epithelial cells, oval fat bodies, bacteria, yeasts, and crystals (including types of crystals) under high-power-field microscopy and the presence of WBC casts, RBC casts, granular casts, hyaline casts, and RTE casts under low-power microscopy.
The laboratory procedure states that UA should be performed within 2 hours of collection if not refrigerated and within 8 hours of collection if refrigerated. In practice, UA results typically are available within 4 hours after collection. The clinical laboratory uses either a manual (Multistix 10 SG Reagent Strips; Bayer Corp, Elkhart, IN) or automated (Clinitek Atlas; Bayer Corp) method for the appearance, specific gravity, and chemistry portion of the UA. Uncentrifuged urine is used for this part of the assay. Microscopic examination is performed only when the urine is not clear or yellow, urine is turbid, or leukocyte esterase, nitrite, blood, or protein is detected. For microscopy, urine is centrifuged at 2,200 rpm for 5 minutes. Most of the supernatant was decanted, leaving 1 mL in the tube. The pellet was resuspended in the remaining 1 mL of supernatant by using a vortex mixer at moderate speed. The resultant mixture was transferred to a slide, allowing the covered chamber to fill by capillary action. After 1 minute, sediment was examined using original magnification ϫ100 objective and low-light conditions (condenser down) for the presence of casts and mucus and original magnification ϫ400 objective and moderate light conditions (condenser up) for the presence of RBCs, WBCs, RTEs, transitional cells, epithelial cells, oval fat bodies, crystals, and microbes. A copy of the laboratorygenerated UA report was used for subsequent data analysis.
Using the laboratory-generated UA and the UA generated by nephrologist A, 2 nephrologists (nephrologist A and nephrologist B) assigned 1 or more clinical diagnoses to each patient. Nephrologists A and B knew only that the patient had ARF and whether urine was a catheterized specimen, but were blinded to the remainder of the patient's clinical history. Urine results were presented in random order to prevent any possible correlation between the laboratory and nephrologist UAs for an individual patient. The 2 nephrologists were blinded to each other's diagnosis. Having nephrologist A review laboratory UA reports and assign a diagnosis to each patient addressed potential bias from interobserver variability. Criteria for diagnosing acute tubular necrosis, tubulointerstitial nephritis, urinary tract infection, and glomerulonephritis are the usual guidelines taught to medical students, residents, and nephrology fellows, listed in Table 1 . In the event of more than 1 diagnosis, the primary diagnosis was listed first.
Criteria for Concordance
A third nephrologist reviewed the patient's chart and recorded the cause of ARF as determined by the consulting nephrologist. The diagnosis given by the consulting nephrolo- Abbreviations: ATN, acute tubular necrosis; GN, glomerulonephritis; TIN, tubulointerstitial disease; UTI, urinary tract infection; TTP, thrombotic thrombocytopenic purpura; HRS, hepatorenal syndrome; DN, diabetic nephropathy; HIVAN, HIV-associated nephropathy.
TSAI ET AL gist was considered the gold standard because he or she had full access to the patient's clinical history and course. When the consulting nephrologist assigned specific glomerular diagnoses, eg, diabetic nephropathy, human immunodeficiency virus-associated nephropathy, lupus nephritis, or postinfectious glomerulonephritis, these were simplified to "glomerulonephritis" ( Table 2 ). Diagnoses of acute tubular necrosis, tubulointerstitial nephritis, urinary tract infection, hepatorenal syndrome, and prerenal azotemia were recorded as such (Table 2) . Again, the first diagnosis listed is the primary one. The primary (first) diagnosis assigned by nephrologist A and nephrologist B for each patient was compared with the gold standard primary diagnosis. If both the consult nephrologist and study nephrologist gave the same cause for ARF, the diagnosis was recorded as concordant for that instance.
Statistical Analysis
The sign test was used to compare the accuracy of the diagnosis between nephrologist A's direct review of urine sediment and nephrologist B's interpretation of either the clinical laboratory UA report or nephrologist A's UA report. The sign test also was used to compare the accuracy of diagnosis between nephrologist A's interpretation of the clinical laboratory UA and his direct review of urine sediment and between nephrologist B's interpretation of either nephrologist A's UA report or the clinical laboratory UA report.
Differences in the elements of urinary sediment reported by nephrologist A compared with the clinical laboratory UA report were analyzed by means of multivariate analysis of variance. Table 2 lists diagnoses assigned by the nephrology consultation team (gold standard), the blinded nephrologist who performed the UA (nephrologist A), and a second nephrologist (nephrologist B) after reading the laboratory reports. In addition, Table 2 lists diagnoses of nephrologist B based on her review of nephrologist A's UA and nephrologist A's diagnoses based on his review of the laboratory UA. The original diagnoses extracted from the patients' charts are listed in the first column, which then are simplified into broad categories, such as glomerulonephritis/ glomerulonephropathy or tubulointerstitial nephritis, listed in the second column.
RESULTS
According to diagnoses of the nephrology consult service, for the 26 patients who developed ARF, 21 patients (81%) had acute tubular necrosis, 2 patients (8%) had prerenal azotemia, 6 patients (23%) had glomerulonephritis (either chronic or acute), 1 patient (4%) had tubulointerstitial disease, 2 patients (8%) had urinary tract infection (which may or may not be related to ARF), and 1 patient (4%) had thrombotic thrombocytopenic purpura.
Compared with the consult service, nephrologist A correctly diagnosed the cause of ARF in 24 patients (92%) when he examined the urine. Nephrologist B was correct only 5 times (19%) using the laboratory UA report, but improved to 69% (18 patients) when she reviewed nephrologist A's UA report. When nephrologist A reviewed the clinical laboratory UA report, he correctly assigned the diagnosis in only 6 cases (23%; Table 3 ).
Comparing the accuracy of the methods used in determining diagnosis, nephrologist A's review of urine sediment was significantly more accurate than either nephrologist A's or nephrologist B's interpretation of the clinical laboratory UA report (Table 4) . When nephrologist B reviewed nephrologist A's UA report, her diagnoses were significantly more accurate than those derived from either her or nephrologist A's interpretation of the clinical laboratory UA report. There were no differences in accuracy of diagnoses between nephrologist A's and nephrologist B's interpretation of the clinical laboratory UA report. There was a tendency toward a greater frequency of correct diagnoses when nephrologist A looked at the urine sediment directly compared with nephrologist B's interpretation of nephrologist A's UA report, but this did not reach statistical significance (P ϭ 0.07; Table 4 ).
Significant differences also exist between nephrologist A's microscopy report compared with the clinical laboratory's report. Using multivari- ate analysis of variance, nephrologist A reported a higher number of RTE cells (P Ͻ 0.0001), granular casts (P ϭ 0.0017), hyaline casts (P ϭ 0.0233), and RTE casts (P ϭ 0.0008), whereas the laboratory reported a higher number of squamous epithelial cells (P ϭ 0.0034). There were no significant differences in the reporting of other urinary sediments, including WBCs, WBC casts, RBCs, RBC casts, transitional epithelial cells, oval fat bodies, bacteria, yeast, and crystals (Tables 5 and 6 ). Nephrologist A reported the presence of acanthocytes in 7 urinary samples that were not detected by laboratory personnel. Five of these 7 patients had glomerulonephritis or glomerulonephropathy as their consult service diagnosis.
DISCUSSION
Performance of UA is vital in the evaluation of patients with kidney disease, especially in differentiating the causes of ARF.
1-6 Our study shows several significant differences between interpretation of UAs performed by a nephrologist compared with those performed by licensed medical technologists or clinical medical scientists in the clinical laboratory. To objectively assess which interpretation is most correct, we set the diagnosis established by the nephrology consult service as the gold standard. Two study nephrologists assigned a diagnosis to each patient by using results of a nephrologist-or laboratoryperformed UA. Both nephrologists were blinded to patient clinical history. Blinding to the clinical history is key in this analysis because Flach et al 11 reported that clinical history influences interpretation of the UA and may lead to an inaccurate diagnosis.
Analysis of data shows that the nephrologist, blinded to clinical history, was able to make the correct diagnosis greater than 90% of the time simply by performing the UA. Nephrologist A was correct in only approximately 23% of cases relying on his interpretation of the clinical laboratory UA report, and similarly, nephrologist B was correct in only approximately 19% of cases relying on the same clinical laboratory report. This improved to approximately 69% correct diagnoses when nephrologist B reviewed nephrologist A's UA report. Although it did not reach statistical significance, there is a suggestion that nephrologist A's interpretation of his own performance of the UA was superior to nephrologist B's interpretation of nephrologist A's UA report. This suggests there may be additional benefit of actual visualization of urinary sediment, rather than relying solely on the UA report of the nephrologist. Thus, nephrologist UA performance is superior to the clinical laboratory UA in determining the correct diagnosis.
Comparing urinary sediment reports, the nephrologist reported significantly more RTE cells, RTE cell casts, and granular casts than UA reports of the clinical laboratory. Conversely, the clinical laboratory had significantly greater reporting of squamous epithelial cells. It is possible that RTE cells were misread by the clinical laboratory as squamous epithelial cells. Acute tubular necrosis is one of the most common causes of ARF, and the hallmarks of the laboratory diagnosis of acute tubular necrosis include the presence of RTE cells, RTE casts, and/or granular casts. Because the nephrologist was more adept than the clinical laboratory at identifying these elements of urinary sediment, this led to much greater accuracy in making the correct diagnosis (Fig 1) .
There was no quantitative difference between the nephrologist and laboratory UAs on reporting of RBCs. However, the laboratory UA report did not comment on RBC morpho- NOTE. Cell counts were measured per high-power field (original magnification ϫ400), and casts, per low-power field (original magnification ϫ100). Proteinuria, nitrites, and leukocyte esterase were detected by urinary dipstick.
Abbreviations: Neg, negative; pos, positive; mod, moderate. NOTE. Proteinuria, nitrites, and leukocyte esterase were detected by urinary dipstick. Cell counts were measured per high-power field (original magnification ϫ400), and casts, per low-power field (original magnification ϫ100).
Abbreviations: Neg, negative; pos, positive; mod, moderate.
TSAI ET AL logical characteristics, whereas the nephrologist noted the presence of acanthocytes in 7 samples. Acanthocytes are dysmorphic RBCs that have a ringform appearance with vesicleshaped protrusions and indicate a glomerular source for hematuria. [12] [13] [14] The ability of the nephrologist to recognize acanthocytes may have improved his ability to make the correct diagnosis: nephrologist A correctly diagnosed glomerulonephritis/glomerulonephropathy in all 6 patients, whereas nephrologist B was successful in identifying only 2 of the 6 patients based on her review of the laboratory UA report.
Acute tubular necrosis was the primary cause of ARF in 21 patients (81%). Brivet et al 15 reported a similar percentage of acute tubular injury in their patients with ARF (78%), whereas Llano and Pasqual 16 noted that 45% of their patients had acute tubular necrosis and 21% had prerenal azotemia. The percentage of prerenal causes probably is lower in our study because such causes for ARF may be recognized more easily and treated quicker with volume resuscitation, obviating the need for nephrology consultations.
16,17
Although results of the current study reflect UA practices of the clinical laboratory of only 1 academic medical center, it is the consensus of the nephrology faculty at our institution who have worked at other medical centers that the problem is more widespread, and there are major discrepancies between UAs performed by clinical laboratories and those performed by nephrologists. Fogazzi and Grignani 9 surveyed urine microscopy practices in Italian renal units. More than 40% of nephrologists were dissatisfied with UAs performed by out- side clinical laboratories, and 92% of nephrologists preferred to perform UAs themselves. The problem appears to be that clinical laboratory personnel who perform UAs (licensed medical technologists, clinical medical scientists) do not identify key components of urinary sediment, such as RTE cells and casts, granular casts, and acanthocytes, that are essential in evaluating patients with acute renal disease. The practice in our clinical laboratory of allowing refrigeration of urine and up to 8 hours to elapse before performing UA likely compromises their ability to detect RBC casts, dysmorphic RBCs, and other formed elements accurately because these may degrade with time and refrigeration. Because our study focused on hospitalized patients with ARF, we are unable to comment directly on the impact of laboratory-performed UAs in the outpatient setting. However, given the underreporting of acanthocytes, relying on laboratory UA reports likely will decrease the ability to diagnose accurately glomerular sources of hematuria and hence glomerulonephritis in the outpatient setting.
CLIA was enacted in 1988 in response to reports of errors in laboratory testing 8 and has had a significant impact on access of physicians to laboratory services. According to data from the 1995 Survey of Physician Office Laboratories, almost two thirds of physicians have eliminated some or all in-office laboratory tests. More than 64% of physicians cited CLIA as a factor in their decision to decrease or eliminate in-office laboratory testing. Of physicians previously performing in-office laboratory testing, more than 70% have chosen to send specimens and patients to outside laboratories. 7 Born and Thran 7 suggested that this trend may result in greater inconvenience for patients and delays in diagnosis and treatment. Beyond delay in diagnosis and treatment, our study suggests that physicians relying on the clinical laboratory UA report to evaluate their patients with acute renal disease may be misled. Although CLIA permits provider-performed microscopy with appropriate CLIA certification, 18 the guidelines have ignored the important role of the nephrologist in training other physicians and medical students to perform and interpret UAs. 9 The renowned academic nephrologist Dr Princella Kincaid-Smith 19 once wrote, "the best doctors do urine microscopy themselves and so may have the satisfaction of making a clear-cut diagnosis of glomerulonephritis directly after seeing the patient."
19 Physicians and physicians in training should be encouraged to learn and perform the art of urine microscopic analysis in evaluating their patients with kidney disease. Moreover, CLIAcertified clinical laboratories need to review their UA procedures and practices and should institute quality control measures that include instruction and oversight by nephrologists trained in the art of urine microscopy.
